CLINICAL_TRIALS
trial_result
· 2012-10-11
Clinical Trial Update: Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan [Phase 2, Phase 3]
Summary
This update notes the completion of Phase 2 and Phase 3 trials of ONO-1101 for postoperative supraventricular tachyarrhythmia in Japan.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Postoperative Supraventricular Tachyarrythmia | Phase 2, Phase 3 | Status: COMPLETED